Two PMS2 Mutations in a Turcot Syndrome Family with Small Bowel Cancers
Marco Agostini(University of Padua), Alessandra Viel(Centro di Riferimento Oncologico), Emanuela Lucci‐Cordisco, Luigi Boccuto(Greenwood Genetic Center), Salvatore Pucciarelli(Azienda Ospedale - Università Padova), Hans Morreau(Leiden University Medical Center), Carlo Capella(University of Insubria), Mauro Boiocchi(Centro di Riferimento Oncologico), Maria Grazia Tibiletti(University of Insubria), Anna Maria Chiaravalli(Ospedale di Circolo e Fondazione Macchi), Daniela Furlan(University of Insubria)
Cited by 63
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
|Journal of Clinical Oncology|2010|541
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
|The Journal of Immunology|2009|383
Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of “Stealthy” Nanomaterials
|Frontiers in Bioengineering and Biotechnology|2020|365